
Europe Veterinary Orthopedic Implants Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The Europe veterinary orthopedic implants market size was estimated at USD 189.6 million in 2024. The market is expected to grow from USD 202.1 million in 2025 to USD 410.3 million in 2034, at a CAGR of 8.2%, according to the latest report published by Global Market Insights Inc.

The market is witnessing rapid growth due to the increasing incidence of bone fractures, ligament injuries, and joint diseases in pets. Pet ownership has been on the rise in European nations, resulting in a larger population of animals in need of advanced medical treatment. For instance, according to the European Pet Food Industry Federation (FEDIAF) “Facts & Figures 2025” report, which is based on data from 2023, pet ownership has grown to 139 million European households, equaling 49% of households owning a companion animal. Such a high pet population in the region increases the demand for various pet care services, including surgeries, thereby driving the market growth.
Veterinary orthopedic implants are medical devices used for correcting fractures, stabilizing joints, and assisting bone healing in animals. Such implants consist of bone plates, screws, pins, wires, and prosthetic joints customized to resist the biomechanical stresses of various species. The Europe market is influenced by the presence of major players such as DePuy Synthes (Johnson & Johnson), B. Braun VetCare, Movora (Vimian Group AB), Arthrex Vet Systems, and Integra LifeSciences. They shape the market through innovation in implant materials and design, provision of training and surgical assistance to veterinarians, and growing distribution networks in Europe.
During 2021-2023, Europe veterinary orthopedic implants market witnessed steady growth, growing from USD 159.1 million to USD 178.1 million in 2023. From 2021 to 2023, one of the key trends in the Europe market was the increasing use of advanced fixation devices such as locking plates, intramedullary nails, and patient-specific 3D-printed implants for pet animals. This shift was driven by the growing demand for higher success rates in fracture repair, faster recovery, and the ability to treat complex cases in dogs, cats, and equines. Veterinary clinics in Europe increasingly made investments in advanced surgical equipment and implants, with the backing of increased pet healthcare spending and insurance. This trend helped the market by growing the scope of conditions that could be treated, enhancing surgical success, and boosting pet owners' confidence in undergoing complex orthopedic procedures, thus raising the overall volume of implant adoption.
Veterinary orthopedic implants are artificial components used in veterinary medicine to restore function to fractured bones or replace damaged joints, bones or cartilage. These implants are made of metals such as titanium or stainless steel. The implants serve to manage fractures, joint disorders, and other musculoskeletal afflictions in animals.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2024 |
| Market Size in 2024 | USD 189.6 Million |
| Market Size in 2025 | USD 202.1 Million |
| Forecast Period 2025 to 2034 CAGR | 8.2% |
| Market Size in 2034 | USD 410.3 Million |
| Key Market Trends | |
| Drivers | Impact |
| Rising pet ownership and humanization | More Europeans are treating pets as family members, leading to a higher willingness to invest in advanced treatments. This trend directly fuels demand for orthopedic implants that improve mobility and quality of life. |
| Aging companion-animal population | Longer pet lifespans have resulted in more cases of fractures, hip dysplasia, and arthritis. These conditions frequently require surgical intervention supported by implants, boosting market growth. |
| Ongoing product innovation | Advancements in implant materials, designs, and surgical tools are delivering better clinical outcomes. These innovations encourage veterinarians to recommend implants more frequently, expanding adoption. |
| Pitfalls & Challenges | Impact |
| High cost of procedures | Orthopedic implant surgeries are expensive due to costly devices and specialized surgical expertise. This makes them unaffordable for many pet owners, especially in price-sensitive regions. |
| Shortage of skilled surgeons | Advanced orthopedic procedures require highly trained specialists, but many regions still face a shortage. This restricts access to complex surgeries outside major veterinary centers. |
| Competition from non-surgical alternatives | Physiotherapy, braces, and medications offer cheaper, less invasive management options. These alternatives reduce the need for implant-based interventions in some cases. |
| Opportunities: | Impact |
| Expansion into underpenetrated regions | Eastern and Southern Europe present strong growth prospects with rising pet ownership and improving veterinary infrastructure. Companies entering early can capture untapped demand. |
| Development of advanced biomaterials | Development of new resorbable materials and antimicrobial coating enhances implant safety and effectiveness. Such innovations will allow differentiation and premium pricing. |
| Market Leaders (2024) | |
| Market Leaders |
Collective market share in 2024 is ~31.8% |
| Top Players |
Collective market share in 2024 is Market Share 52.5% |
| Competitive Edge |
|
| Regional Insights | |
| Largest Market | Germany |
| Fastest growing market | France |
| Emerging countries | Italy, Spain, Netherlands, and Poland |
| Future outlook |
|

The Europe market was valued at USD 159.1 million and USD 168 million in 2021 and 2022, respectively. The market size reached USD 189.6 million in 2024, growing from USD 178.1 million in 2023.
Based on the product, the Europe market is divided into implants and instruments. The implants segment is further sub-segmented into plates, joint implants, bone screws and anchors, pins and wires, and other implants. The implants segment dominated the market in 2024 with USD 134.9 million and is poised to capture a market size of USD 296.4 million by 2034.

Based on animal type, the Europe veterinary orthopedic implants market is categorized into small and medium animals and large animals. The small and medium animals’ segment is further categorized into dogs, cats, and other small and medium animals. The small and medium animals segment dominated the market in 2024 with a market share of 72.3%. The large animal’s segment, on the other hand, accounted for a share of 27.7% in the Europe market. Livestock animals such as pigs, sheep, and goats play a crucial role in agriculture and the economy. The increasing demand for meat, dairy, and wool products has led to intensified livestock farming practices. This intensification can result in a higher incidence of orthopedic issues due to factors such as confined spaces and rapid growth rates, thereby driving the need for veterinary orthopedic interventions.
Based on the application, the Europe veterinary orthopedic implants market is categorized into Tibial Plateau Leveling Osteotomy (TPLO), Tibial Tuberosity Advancement (TTA), joint replacement, trauma, and other applications. The joint replacement segment is further sub-categorized into hip replacement, knee replacement, elbow replacement, and ankle replacement. The joint replacement segment held a share of 28% in 2024 and is poised to grow at a considerable rate of 8.8% during the forecast year.
Based on the end use, the Europe veterinary orthopedic implants market is categorized into veterinary hospitals and clinics and other end users. The veterinary hospitals and clinics segment accounted for revenue of USD 163.7 million in 2024 and is anticipated to grow at a CAGR of 8.4% over the analysis period.

The Germany veterinary orthopedic implants market was valued at USD 34.4 million and USD 36.2 million in 2021 and 2022, respectively. The market size reached USD 40.8 million in 2024, growing from USD 38.4 million in 2023.
France is witnessing robust growth in the Europe veterinary orthopedic implants market and is anticipated to grow at a CAGR of 9.1% between 2025 - 2034.
UK held a significant share of 16.5% in Europe veterinary orthopedic implants industry.
The veterinary orthopedic implants market is witnessing substantial growth, fueled by the increasing prevalence of orthopedic conditions in companion and farm animals, a surge in pet ownership, and the rising demand for advanced surgical procedures. This market encompasses leading global healthcare companies, medical device manufacturers, and veterinary-focused firms delivering innovative orthopedic solutions. The top 5 market players in the Europe market, including DePuy Synthes (Johnson & Johnson), B. Braun VetCare, Movora (Vimian Group AB), Arthrex Vet Systems, and Integra LifeSciences, account for ~52.5% of the market. These industry players undertake strategic initiatives, such as product launches and approvals, assisting them in sustaining market competition.
Further, technological advancements such as 3D printing, customized implant design, and minimally invasive surgical techniques are revolutionizing veterinary orthopedics. Additionally, growing veterinary infrastructure, strategic collaborations with veterinary hospitals, and investments in research and development are driving market expansion. The focus on sustainability, affordability, and enhanced implant biocompatibility ensures continued innovation to meet the evolving needs of veterinary surgeons and animal healthcare providers.
Few of the prominent players operating in the Europe veterinary orthopedic implants industry include:
DePuy Synthes, a subsidiary of Johnson & Johnson, is a key player in the veterinary orthopedic implants market, accounting for ~31.8% of the market share. The company offers a wide range of implants and instruments designed to address fractures, joint issues, and musculoskeletal conditions in companion animals. Strategic partnerships with veterinary hospitals and continued investments in research and development solidify its leadership position, supporting the development of next-generation implants tailored to veterinary needs.
Movora, a subsidiary of Vimian Group AB, operates exclusively within the veterinary orthopedic implants market, offering a dedicated range of implants and surgical instruments. The company focuses on developing innovative orthopedic solutions, including advanced joint replacement systems, plates, and fixation devices tailored specifically for companion animals. Movora invests heavily in research, ensuring product quality, durability, and surgical precision.
B. Braun VetCare holds a strong position in the Europe market by offering a wide range of high-quality plates, screws, and surgical instruments tailored for small and medium animals. The company’s focus on precision-engineered implants and comprehensive surgical kits ensure reliable outcomes, which strengthens surgeon preference. Their emphasis on innovation and safety has helped maintain a competitive edge in the growing orthopedic segment.
Market, By Product
Market, By Animal Type
Market, By Application
Market, By End Use
The above information is provided for the following countries:
The market size was USD 189.6 million in 2024, driven by increasing pet ownership, rising cases of fractures and joint disorders, and higher veterinary healthcare spending.
The market is expected to reach USD 410.3 million by 2034, growing at a CAGR of 8.2% from 2025 to 2034, supported by innovations in implant design, 3D printing, and advanced biomaterials.
The Europe market is expected to be valued at USD 202.1 million in 2025, reflecting steady growth from 2024.
The implants segment dominated with USD 134.9 million in 2024, accounting for 71.2% share of the market.
The instruments segment accounted for USD 54.7 million in 2024, representing 28.8% of the market.
Small and medium animals, particularly dogs and cats, dominated the market with 72.3% share in 2024, due to high prevalence of ligament injuries, fractures, and joint disorders.
The joint replacement segment, including hip, knee, and elbow replacements, is projected to grow at a CAGR of 8.8% through 2034, driven by aging pet populations and demand for mobility-restoring procedures.
Germany leads the market with USD 40.8 million in 2024, supported by strong veterinary infrastructure, rising pet ownership, and advanced animal healthcare systems.
Key players include DePuy Synthes (Johnson & Johnson), B. Braun VetCare, Movora (Vimian Group AB), Arthrex Vet Systems, Integra LifeSciences, Veterinary Instrumentation, Rita Leibinger, Orthomed, and BlueSAO.


